News about "Quotient Sciences completes integration of drug su"

Quotient Sciences completes integration of drug substances into translational pharmaceuticals platform

Quotient Sciences completes integration of drug substances into translational pharmaceuticals platform

The full integration of drug substance R&D and manufacturing follows a year after the company's acquisition of its Alnwick, UK site and provides a more streamlined approach from candidate selection through to commercialization. Quotient Sciences Translational Pharmaceutics approach combining manufacturing and clinical dosing at a single organization

Quotient Sciences Completes Integration Of Drug Su | 18/02/2022 | By Darshana 494


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members